Skip to main content

Breadcrumb

  1. Home

FUnctional diagnoSIs of corONary Stenosis (FUSION)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about FUnctional diagnoSIs of corONary Stenosis (FUSION)

Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian

A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

Actigraphy Improvement With Voxelotor (ActIVe) Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Actigraphy Improvement With Voxelotor (ActIVe) Study

TTVR Early Feasibility Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about TTVR Early Feasibility Study

Cancer and Blood Pressure Management, CARISMA Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Cancer and Blood Pressure Management, CARISMA Study

TRISCEND II Pivotal Trial

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about TRISCEND II Pivotal Trial

Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer

A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Cas

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Cas

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 215
  • Page 216
  • Page 217
  • Page 218
  • Page 219
  • Page 220
  • Page 221
  • Page 222
  • Page 223
  • …
  • Next page Next
  • Last page Last
Subscribe to